News | March 09, 2023
Evonik opens new facility for pharmaceutical lipids in Germany
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
lAIH strives to introduce appropriate interventions for nurturing an AMR innovation ecosystem in the country through cohesive efforts across the innovation pyramid
This order is subject to initial advance payment as per the agreed terms of the contract and this order will be executed within 6 to 8 months.
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
The company has announced net revenue of Rs. 639.8 crore for Q3 FY23 as compared to Rs. 562.08 crore in the corresponding period of the previous year
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
